XML 38 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
Collaborative Research and Development Agreements (Tables)
 9 Months Ended
Sep. 30, 2017
Astra Zeneca  
Summary of Revenue Recognized under Various Agreements

The following table summarizes the revenues earned under our agreement with AstraZeneca, included as collaboration revenue in our consolidated statements of operations (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Initial payment

$

-

 

 

$

-

 

 

$

-

 

 

$

521

 

Subsequent payment

 

-

 

 

 

-

 

 

 

-

 

 

 

1,953

 

Performance of research activities

 

-

 

 

 

-

 

 

 

-

 

 

 

104

 

Total

$

-

 

 

$

-

 

 

$

-

 

 

$

2,578